Table 1. The miR-34a expression and clinic-pathological features in esophageal squamous carcinoma patients.
| Clinical feature | MiR-34a expression | |||
|---|---|---|---|---|
| Cases | High (N, %) | Low (N, %) | P value | |
| Age | ||||
| <65 | 60 | 18 (72.0) | 42 (79.2) | 0.567 |
| ≥65 | 18 | 7 (28.0) | 11 (20.8) | |
| Sex | ||||
| Male | 53 | 15 (60.0) | 38 (71.7) | 0.436 |
| Female | 25 | 10 (40.0) | 15 (28.3) | |
| Histologic grade | ||||
| G1 | 8 | 2 (8.0) | 6 (11.3) | 0.719 |
| G2+G3 | 70 | 23 (92.0) | 47 (88.7) | |
| Invasion depth | ||||
| T1+T2 | 59 | 20 (80.0) | 39 (73.6) | 0.587 |
| T3+T4 | 19 | 5 (20.0) | 14 (26.4) | |
| Lymphatic invasion | ||||
| Negative | 39 | 7(28.0) | 32 (60.4) | 0.014* |
| Positive | 39 | 18 (72.0) | 21 (39.6) | |
| TNM stage | ||||
| I/II | 55 | 13 (52.0) | 42 (79.2) | 0.018* |
| III/IV | 23 | 12 (48.0) | 11 (20.8) | |
TNM, tumor node metastasis.
χ2 test was used to analyze the categorical variables. *P < 0.05.